Furthermore, the restoration of AKT or constitutively active AKT expression could rescue the inhibition of cell proliferation by ANP32B deficiency, suggesting the inhibition of cell proliferation by ANP32B deficiency is primarily mediated through AKT activation in breast cancer cells. This evidence concerns the gene AKT1 and breast cancer.